Sandbox:Sara: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(67 intermediate revisions by the same user not shown)
Line 3: Line 3:
{{CMG}}; {{AE}} {{S.M.}}
{{CMG}}; {{AE}} {{S.M.}}


{| class="wikitable"
 
|+Knowing individual skin type and using the right sunscreen accordingly
 
! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|'''Skin type by the Fitzpatrick Scale'''}}
<ref name="pmid27261907">{{cite journal| author=Mao Y, Yang D, He J, Krasna MJ| title=Epidemiology of Lung Cancer. | journal=Surg Oncol Clin N Am | year= 2016 | volume= 25 | issue= 3 | pages= 439-45 | pmid=27261907 | doi=10.1016/j.soc.2016.02.001 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27261907  }} </ref>
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|'''Skin color'''}}
 
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|'''Skin tone or other common descriptors'''}}
[[File:Atypical Bcell gif.gif|thumb|200px|none|High-power field of peripheral blood smear revealing a large, atypical B cell with mild cytoplasmic expansion, coarse chromatin, multiple distinct nucleoli and peripheral vacuolation.[https://openi.nlm.nih.gov/detailedresult.php?img=PMC2944189_1752-1947-4-300-2&query=waldenstrom+macroglobulinaemia&it=xg&req=4&npos=17 Source: Charakidis M. et al, Department of Haematology-Oncology, Royal Hobart Hospital, Tasmania, 7000, Australia.]]]
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|'''Sun exposure effects'''}}
 
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|'''Recommended sunscreen SPF'''}}
 
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|''' 1 MED- Minimal erythemal dose (as SED- standard erythemal dose)'''}}
{|  
! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|''' Susceptibility to skin cancer'''}}
|+'''Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders'''
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Criteria
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Symptomatic WM
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Asymptomatic WM
! style="background:#4479BA; color: #FFFFFF;" align="center" + |IgM-Related Disorders
! style="background:#4479BA; color: #FFFFFF;" align="center" + |MGUS
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |'''I'''
! align="center" style="background:#DCDCDC;" + |IgM monoclonal protein
|
| style="background:#F5F5F5;" align="center" + | +
* [[Pale skin|Pale]] white
| style="background:#F5F5F5;" align="center" + | +
|
| style="background:#F5F5F5;" align="center" + | +
* [[Paleness|Pale]] or [[albino]], [[freckles]] common ([[Celtic (water)|Celtic]])
| style="background:#F5F5F5;" align="center" + | +
|
* Always [[burns]]
* Never tans
| rowspan="2" |30+  
|
* 2-3
|
* Very high
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |'''II'''
! align="center" style="background:#DCDCDC;" + |Bone marrow infiltration
|
| style="background:#F5F5F5;" align="center" + | +
* White
| style="background:#F5F5F5;" align="center" + | +
|
| style="background:#F5F5F5;" align="center" + | -
* [[Light]] or fair (European)
| style="background:#F5F5F5;" align="center" + | -
|
* Always [[burns]]
* Rarely tans
|
* 3-4
|
* Very high
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |'''III'''
! align="center" style="background:#DCDCDC;" + |Symptoms attributable to IgM
|
| style="background:#F5F5F5;" align="center" + | +
* White
| style="background:#F5F5F5;" align="center" + | -
|
| style="background:#F5F5F5;" align="center" + | +
* [[Light]]‐intermediate (Dark European)
| style="background:#F5F5F5;" align="center" + | -
|
* Sometimes [[burns]]
* Sometimes tans
| rowspan="4" |15+
|
* 4-5
|
* High
|-
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |'''IV'''
! align="center" style="background:#DCDCDC;" + |Symptoms attributable to tumor infiltration
|
| style="background:#F5F5F5;" align="center" + | +
* [[Light]] brown
| style="background:#F5F5F5;" align="center" + | -
|
| style="background:#F5F5F5;" align="center" + | -
* [[Olive]] with/without [[brown]] tint (Mediterranean)
| style="background:#F5F5F5;" align="center" + | -
|
|}<br />
* Tans easily
*[[Burns]] less
|
* 5-6
|
* Moderate
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |'''V'''
|
* Dark [[brown]]
|
* [[Brown]]
|
* Tans easily
* Rarely [[burns]]
|
* 8-12
|
* Low
|-
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" |'''VI'''
|
* [[Black]]
|
* [[Black]]
|
* Does not [[burn]]
|
* 16-24
|
* Low
|}
 
 




Line 99: Line 47:




==References==
==Reference==
{{Reflist|2}}
{{Reflist|2}}

Latest revision as of 18:18, 11 December 2020


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]


[1]

High-power field of peripheral blood smear revealing a large, atypical B cell with mild cytoplasmic expansion, coarse chromatin, multiple distinct nucleoli and peripheral vacuolation.Source: Charakidis M. et al, Department of Haematology-Oncology, Royal Hobart Hospital, Tasmania, 7000, Australia.


Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders
Criteria Symptomatic WM Asymptomatic WM IgM-Related Disorders MGUS
IgM monoclonal protein + + + +
Bone marrow infiltration + + - -
Symptoms attributable to IgM + - + -
Symptoms attributable to tumor infiltration + - - -




Reference

  1. ↑ Mao Y, Yang D, He J, Krasna MJ (2016). "Epidemiology of Lung Cancer". Surg Oncol Clin N Am. 25 (3): 439–45. doi:10.1016/j.soc.2016.02.001. PMID 27261907.
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox:Sara&oldid=1678042"